Skip to content
DataLookout
Menu

NanOlogy, LLC (doing business as Intryx Therapeutics, LLC) clinical trial pipeline

Get alerts when NanOlogy, LLC (doing business as Intryx Therapeutics, LLC)'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: TIGER-1 · Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response Eligibility criteria changed NanOlogy, LLC (doing business as Intryx Therapeutics, LLC)Phase 1/2 NCT07767110
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1/2
1

Disease areas by active trials

Get alerts when NanOlogy, LLC (doing business as Intryx Therapeutics, LLC)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free